Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
04/29/2004 | US20040081972 Detecting antibodies; screening, development therapies for infections, inflammation; polypeptides; monoclonal antibodies |
04/29/2004 | US20040081971 Gastrointestinal disorders; cardiovascular disorders; autoimmune diseases; cell proliferation; antiinflammatory agents |
04/29/2004 | US20040081968 Method and mixture for curing autoimmune disease |
04/29/2004 | US20040081658 Epitopes involved in the immune response to human papillomavirus; induction and/or enhancement of a T cell response directed towards an antigen, using peptides comprising specific epitopes for said antigen |
04/29/2004 | US20040081648 Adzymes and uses thereof |
04/29/2004 | US20040081647 For inhibiting receptor-mediated signaling activity of an extracellular substrate polypeptide |
04/29/2004 | US20040081646 Group B Streptococcal phage lysin |
04/29/2004 | CA2503347A1 Monoclonal antibodies specific for cariogenic bacteria |
04/29/2004 | CA2502539A1 Protein modification |
04/29/2004 | CA2502201A1 Protein synthesis system using xenopus oocyte extract |
04/29/2004 | CA2502029A1 Site specific incorporation of keto amino acids into proteins |
04/29/2004 | CA2500653A1 Glycoprotein synthesis |
04/29/2004 | CA2498213A1 Induction of gene expression using a high concentration sugar mixture |
04/29/2004 | CA2496840A1 Screening antibodies using an optical fiber array device capable of simultaneously performing multiple functional assays |
04/29/2004 | CA2496741A1 Screening compound libraries using an optical fiber array device capable of simultaneously performing multiple functional assays |
04/28/2004 | EP1413587A2 Modified complement system regulator |
04/28/2004 | EP1412758A2 Protein arrays, methods for their preparation and methods for the detection of intermolecular interactions |
04/28/2004 | EP1412757A2 Method for identification of proteins from intracellular bacteria |
04/28/2004 | EP1412748A2 Mage-a3 peptides presented by hla class ii molecules |
04/28/2004 | EP1412747A1 Method and means for detecting alcohol consumption |
04/28/2004 | EP1412538A2 Methods for the simultaneous detection of hcv antigens and hcv antibodies |
04/28/2004 | EP1412513A2 Phosphate limited inducible promoter and a bacillus expression system |
04/28/2004 | EP1412505A2 Dna sequences for regulating transcription |
04/28/2004 | EP1412504A2 Methods of rna and protein synthesis |
04/28/2004 | EP1412503A2 A fusion protein |
04/28/2004 | EP1412502A2 Use of clya hemolysin for excretion of fusion proteins |
04/28/2004 | EP1412499A2 Cytokine polypeptides |
04/28/2004 | EP1412498A2 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby |
04/28/2004 | EP1412388A1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
04/28/2004 | EP1412387A2 Transporters and ion channels |
04/28/2004 | EP1412385A2 Modified insulin with reduced immunogenicity |
04/28/2004 | EP1412382A2 Interferon gamma polypeptide variants |
04/28/2004 | EP1412381A2 Meningococcus adhesins nada, app and orf40 |
04/28/2004 | EP1412379A2 Antigenic polypeptides |
04/28/2004 | EP1412377A1 Production of high molecular mass lectins |
04/28/2004 | EP1412374A2 Novel pgc-1 isoforms and uses therefor |
04/28/2004 | EP1411983A1 Bispecific antibodies that bind to vegf receptors |
04/28/2004 | EP1411980A2 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
04/28/2004 | EP1411969A1 Modified protamine with reduced immunogenicity |
04/28/2004 | EP1411963A2 Cytotoxic factors for modulating cell death |
04/28/2004 | EP1411962A2 Monoclonal antibody therapy for pancreas cancer |
04/28/2004 | EP1411770A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
04/28/2004 | EP1326628B1 Chemokine mutants in the treatment of multiple sclerosis |
04/28/2004 | EP1221054B1 Assays for mastitis detecting haptoglobin in milk |
04/28/2004 | EP1062318B1 A prokaryotic cell comprising two copies of a gene transcribed in different directions |
04/28/2004 | EP1012190A4 Eosinophil eotaxin receptor |
04/28/2004 | EP0944723B1 Mammalian chemokines |
04/28/2004 | EP0910645B1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF I-kappa-B-alpha |
04/28/2004 | EP0910642B1 A method for increasing hemoprotein production in filamentous fungi |
04/28/2004 | EP0856054B1 Monoclonal antibody br110 and uses thereof |
04/28/2004 | EP0799317B1 Method for secreting thrombopoietin polypeptides |
04/28/2004 | EP0784682B1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
04/28/2004 | EP0730469B1 Modified truncated complement system regulators |
04/28/2004 | EP0698095B1 Bmp-10 compositions |
04/28/2004 | CN1492930A Anti-interferon-šŒantibodies |
04/28/2004 | CN1492768A Artificial proteins with reduced immunogenicity |
04/28/2004 | CN1492767A Modified anti-EGFR antibody with reduced immunogenicity |
04/28/2004 | CN1492050A Method for raising fibroblast growth factor expression quantity Pichia yeast secretes and expresses |
04/28/2004 | CN1491624A Modified biological material |
04/28/2004 | CN1147588C Process for preparing peptide antibiotics with efficient expression |
04/28/2004 | CN1147586C Nucleotide sequences of HIV-10 type (or subtype) retrovirus antigens |
04/28/2004 | CN1147584C Modulators of tissue regeneration |
04/28/2004 | CN1147505C G-protein receptor HTNAD 29 |
04/27/2004 | US6727350 Toso |
04/27/2004 | US6727346 Obtaining insulin precursors; generate suspension of insulin and cysteine hydrochloride, heat, recover insulin precursors |
04/27/2004 | US6727225 TWEAK receptor |
04/27/2004 | US6727092 Methods for the simultaneous detection of HCV antigens and HCV antibodies |
04/27/2004 | US6727080 Monoclonal antibodies for use in cancer immunotherapy and their preparation; marker not restricted to previously defined histological classes of cancer |
04/27/2004 | US6726912 Papillomavirus polyprotein constructs |
04/27/2004 | US6726909 Administering antibody |
04/27/2004 | CA2295999C Nik proteins, nucleic acids and methods |
04/27/2004 | CA2152166C Process for detecting fibrocystic desease or a cftr gene mutation |
04/27/2004 | CA2152047C Production of human recombinant collagen in the milk of transgenic animals |
04/27/2004 | CA2058370C Monoclonal antibodies against human tumor necrosis factor .alpha. |
04/22/2004 | WO2004033706A2 Nucleic acids encoding duramycin |
04/22/2004 | WO2004033705A2 Viral interferon antagonists and uses therefor |
04/22/2004 | WO2004033704A1 Method of purifying lantibiotics |
04/22/2004 | WO2004033693A1 Methods vectors plasmids and methods for increasing expression of recombinant polypeptides |
04/22/2004 | WO2004033636A2 Protein modification and maintenance molecules |
04/22/2004 | WO2004033627A2 Methods for efficient production of mammalian recombinant proteins |
04/22/2004 | WO2004033499A1 Cell death-inducing agent |
04/22/2004 | WO2004033486A2 Production of homotrimeric fusion proteins |
04/22/2004 | WO2004032860A2 Hiv vaccine formulations |
04/22/2004 | WO2004032852A2 Methods for treating cardiac arrhythmia and preventing death due to cardiac arrhythmia using ngf antagonists |
04/22/2004 | WO2004032839A2 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
04/22/2004 | WO2004032832A2 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment |
04/22/2004 | WO2004032830A2 Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same |
04/22/2004 | WO2004020639A3 Production of multimeric fusion proteins using a c4bp scaffold |
04/22/2004 | WO2004015059A3 Methods and compositions for in vitro synthesis of biological macromolecules in a cell-free system enriched with atp-sulfurylase |
04/22/2004 | WO2003087318A9 Truncated 24 kda basic fibroblast growth factor |
04/22/2004 | WO2003072014B1 Minicell compositions and methods |
04/22/2004 | WO2003070965A8 The eaat2 promoter and uses thereof |
04/22/2004 | WO2003060084A9 Methods for making polynucleotides and purifying double-stranded polynucleotides |
04/22/2004 | WO2003055994A9 Hxhv virus, nucleic material, peptide material and uses |
04/22/2004 | WO2003046565A3 Ig lambda biopolymer markers predictive of alzheimers disease |
04/22/2004 | WO2003043587A3 Recovery of recombinant human parainfluenza virus type 1 (hpiv1) from cdna |
04/22/2004 | WO2003040345A3 Type 2 cytokine receptor and nucleic acids encoding same |
04/22/2004 | WO2003031566A3 Keratinocyte derived interferon |
04/22/2004 | WO2003027248A8 Antibody inhibitors of gdf-8 and uses thereof |
04/22/2004 | WO2003020763A9 Soluble t cell receptor |